Detalhe da pesquisa
1.
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
N Engl J Med
; 380(13): 1226-1234, 2019 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917258
2.
Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
Breast Cancer Res Treat
; 179(1): 217-227, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571072
3.
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.
Br J Clin Pharmacol
; 81(6): 1134-41, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26859101
4.
Combination anastrozole and fulvestrant in metastatic breast cancer.
N Engl J Med
; 367(5): 435-44, 2012 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22853014
5.
Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.
Pharmacogenomics
; 24(12): 665-673, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615099
6.
The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
Breast
; 60: 295-301, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34728119
7.
Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
BMJ
; 375: e066588, 2021 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34880055
8.
Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancer.
Clin Cancer Res
; 15(2): 708-13, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19147778
9.
Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis.
Breast
; 54: 203-210, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130486
10.
The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
J Geriatr Oncol
; 11(7): 1132-1137, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32611495
11.
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol
; 35(18): 2062-2081, 2017 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618241
12.
Competing risks of death in younger and older postmenopausal breast cancer patients.
World J Clin Oncol
; 5(5): 1088-96, 2014 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25493245
13.
Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors.
Crit Rev Oncol Hematol
; 81(2): 136-50, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21507676
14.
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
J Clin Oncol
; 29(29): 3869-76, 2011 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21911723
15.
Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer.
J Clin Oncol
; 28(1): 77-82, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19901117
16.
Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
J Clin Oncol
; 27(35): 5906-10, 2009 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19858391
17.
Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.
J Clin Oncol
; 27(27): 4536-41, 2009 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19687332